HCA Healthcare, Inc. $HCA Stock Holdings Lowered by Skandinaviska Enskilda Banken AB publ

Skandinaviska Enskilda Banken AB publ trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 133,269 shares of the company’s stock after selling 4,616 shares during the period. Skandinaviska Enskilda Banken AB publ owned 0.06% of HCA Healthcare worth $56,799,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Cerity Partners LLC raised its stake in shares of HCA Healthcare by 13.1% in the 3rd quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after buying an additional 5,092 shares in the last quarter. Savant Capital LLC raised its position in HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after acquiring an additional 1,246 shares in the last quarter. Swiss National Bank boosted its position in shares of HCA Healthcare by 4.3% during the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after purchasing an additional 23,100 shares in the last quarter. Sector Gamma AS lifted its stake in HCA Healthcare by 36.0% during the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after purchasing an additional 2,883 shares during the last quarter. Finally, National Pension Service grew its position in HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after buying an additional 17,531 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Sanford C. Bernstein set a $541.00 target price on HCA Healthcare in a report on Monday, February 9th. Truist Financial boosted their price objective on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. TD Cowen reissued a “buy” rating on shares of HCA Healthcare in a research report on Wednesday, January 28th. Oppenheimer upped their price target on shares of HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Finally, Argus increased their target price on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a report on Friday, February 6th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $523.27.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at $6,171,357.94. This represents a 40.07% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 13,520 shares of company stock valued at $6,894,067. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 0.9%

Shares of NYSE:HCA opened at $539.91 on Tuesday. HCA Healthcare, Inc. has a 12-month low of $295.00 and a 12-month high of $552.90. The firm has a market capitalization of $120.73 billion, a P/E ratio of 19.02, a price-to-earnings-growth ratio of 1.66 and a beta of 1.36. The firm has a fifty day moving average of $483.90 and a two-hundred day moving average of $450.93.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the firm earned $6.22 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a $0.78 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s payout ratio is presently 10.15%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.